Values as of: 2024-09-18
COMMON STOCK | Insurance - Life |
Last Closing
USD 255.84Change
-0.72 (-0.28)%Market Cap
USD 8.63BVolume
0.13MAnalyst Target
USD 146.20Verdict
Verdict
Primerica, Inc., together with its subsidiaries, provides financial products and services to middle-income households in the United States and Canada. The company operates in four segments: Term Life Insurance; Investment and Savings Products; Senior Health; and Corporate and Other Distributed Products. The Term Life Insurance segment underwrites individual term life insurance products. The Investment and Savings Products segment provides mutual funds and various retirement plans, managed investments, variable and fixed annuities, and fixed indexed annuities. The Senior Health segment offers segregated funds; and medicare advantage and supplement plans. The Corporate and Other Distributed Products segment provides mortgage loans; prepaid legal services that assist subscribers with legal matters, such as drafting wills, living wills and powers of attorney, trial defense, and motor vehicle-related matters; ID theft defense services; auto and homeowners' insurance; home automation solutions; and insurance products, including supplemental and accidental death, and disability insurance. It distributes and sells its products through licensed sales representatives. Primerica, Inc. was founded in 1927 and is headquartered in Duluth, Georgia.
Company Website : https://www.primerica.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| AFL | Aflac Incorporated |
-0.60 (-0.55%) |
USD 61.02B |
| MET-PA | MetLife Inc Preferred Stock Se.. |
-0.06 (-0.24%) |
USD 48.43B |
| MET-PE | MetLife Inc Preferred Stock Se.. |
-0.03 (-0.12%) |
USD 44.21B |
| PRU | Prudential Financial Inc |
+0.76 (+0.64%) |
USD 41.04B |
| PUK | Prudential Public Limited Comp.. |
+0.15 (+0.90%) |
USD 22.41B |
| JXN | Jackson Financial Inc |
+1.22 (+1.42%) |
USD 6.06B |
| FG | F&G Annuities & Life Inc. |
-0.22 (-0.52%) |
USD 5.28B |
| ANG-PB | American National Group Inc |
+0.15 (+0.61%) |
N/A |
| ANG-PA | American National Group Inc. |
+0.05 (+0.21%) |
N/A |
| MET-PF | MetLife Inc Preferred Stock Se.. |
+0.01 (+0.04%) |
N/A |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| GDIV | Harbor Dividend Growth Le.. | 2.64 % | 0.00 % |
-0.06 (-0.09%) |
USD 0.27B |
| OSCV | 1.94 % | 0.79 % |
N/A |
N/A | |
| AGED:SW | iShares Ageing Population.. | 0.57 % | 0.00 % |
-0.01 (-0.09%) |
N/A |
| USLB | 0.00 % | 0.35 % |
N/A |
N/A | |
| IUSS | 0.00 % | 0.00 % |
N/A |
N/A | |
| AGED:LSE | iShares Ageing Population.. | 0.00 % | 0.00 % |
-0.05 (-0.09%) |
N/A |
| AGES:LSE | iShares IV Public Limited.. | 0.00 % | 0.00 % |
-5.00 (-0.09%) |
N/A |
| OUSM | 0.00 % | 0.48 % |
N/A |
N/A |
| Market Performance vs. Industry/Classification (Insurance - Life) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 24.34% | 72% | C | 88% | B+ | ||
| Dividend Return | 1.17% | 13% | F | 28% | F | ||
| Total Return | 25.51% | 72% | C | 87% | B+ | ||
| Trailing 12 Months | |||||||
| Capital Gain | 26.65% | 72% | C | 78% | C+ | ||
| Dividend Return | 1.51% | 13% | F | 23% | F | ||
| Total Return | 28.16% | 72% | C | 76% | C+ | ||
| Trailing 5 Years | |||||||
| Capital Gain | 100.53% | 80% | B- | 87% | B+ | ||
| Dividend Return | 8.64% | 8% | B- | 29% | F | ||
| Total Return | 109.17% | 73% | C | 86% | B+ | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 20.96% | 83% | B | 84% | B | ||
| Dividend Return | 22.46% | 78% | C+ | 83% | B | ||
| Total Return | 1.50% | 13% | F | 34% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 28.11% | 50% | F | 37% | F | ||
| Risk Adjusted Return | 79.90% | 89% | A- | 91% | A- | ||
| Market Capitalization | 8.63B | 38% | F | 84% | B | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
The company had positive total cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
